945265-05-4 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indazole, 3-ethyl-5-fluoro-, is used as a building block for the synthesis of potential drug candidates due to its unique chemical structure and properties. Its presence in drug molecules can contribute to the modulation of biological targets, potentially leading to the development of new therapeutic agents.
Used in Research Applications:
In the research industry, 1H-Indazole, 3-ethyl-5-fluoro-, is utilized as a reference standard for analytical testing. Its well-defined chemical structure and properties make it suitable for use in the calibration of analytical instruments and the validation of experimental methods, ensuring the accuracy and reliability of research findings.
Used in Chemical Synthesis:
1H-Indazole, 3-ethyl-5-fluoro-, is employed as an intermediate in the synthesis of more complex organic compounds. Its reactivity and functional groups can be further modified or incorporated into larger molecular frameworks, expanding the scope of chemical research and development.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1H-Indazole, 3-ethyl-5-fluoro-, is used for the design and optimization of novel bioactive molecules. Its structural features can be leveraged to enhance the potency, selectivity, and pharmacokinetic properties of drug candidates, ultimately contributing to the advancement of therapeutic interventions for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 945265-05-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,2,6 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 945265-05:
(8*9)+(7*4)+(6*5)+(5*2)+(4*6)+(3*5)+(2*0)+(1*5)=184
184 % 10 = 4
So 945265-05-4 is a valid CAS Registry Number.
945265-05-4Relevant academic research and scientific papers
INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 147; 148, (2013/02/27)
The present invention relates to a novel indazole- or pyrrolopyridine-derivative, represented by the formula (1) below, that has an agonistic action or a partial agonistic action against serotonin-4 receptor, and a pharmaceutical composition comprising the same. Formula (1) [wherein each substituent is as defined in claim 1]
